Skip to main content

LAM RESEARCH CORP

For the period ended Dec 29, 2024. Filed Jan 31, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Dec 29, 2024 · Filed Jan 31, 2025

LRCX$222.39+0.5%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Unregistered Sales of Equity Securities and Use of Proceeds

ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds

Repurchases of Company Shares

In May 2024, the Board of Directors authorized management to repurchase up to an additional $10.0 billion of Common Stock; this authorization supplements the remaining balance from any prior authorization. These repurchases can be conducted on the open market or as private purchases and may include the use of derivative contracts with large financial institutions, in all cases subject to compliance with applicable law. This repurchase program has no termination date and may be suspended or discontinued at any time.

Share repurchases, including those under the repurchase program, are reflected in the table below. All references to share and per share amounts have been retroactively adjusted to reflect the effects of the stock split. See Note 1, “Basis of presentation,” to our Consolidated Financial Statements, included in Part I of this Form 10-Q for additional information.

Period · Total Numberof SharesRepurchased · Average PricePaid perShare (1) · Total Number ofShares Purchasedas Part of PubliclyAnnounced Plans orPrograms · AmountAvailableUnderRepurchaseProgram
(in thousands, except per share data)
Available balance as of June 30, 2024$10,824,660
Quarter ended September 29, 202411,952$83.9711,9529,821,006
September 30, 2024 - October 27, 20245,595$79.315,5959,377,293
October 28, 2024 - November 24, 20241,212$74.891,2129,286,532
November 25, 2024 - December 29, 20241,529$75.831,5299,170,561
Quarter ended December 29, 20248,336$78.03(2)8,336$9,170,561

Lam Research Corporation 2025 Q2 10-Q 37

(1) Our net share repurchases are subject to a 1% excise tax under the Inflation Reduction Act. Excise tax incurred reduces the amount available under repurchase programs, as applicable, and is included in the cost of shares repurchased in the Condensed Consolidated Statement of Stockholders’ Equity and the calculation of the average price paid per share.

(2) Average price paid per share presented is for the quarter ended December 29, 2024.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.